Skip to main content

Table 6 Multiple regression analyses accounting for factors that affect total pill burden and pill burden from PBs

From: Prescription characteristics of phosphate binders in a high pill burden for hemodialysis patients

   Model 1 Model 2
Total pill burden
(pills/day/patient)
Pill burden from PBs
(pills/day/patient)
Total pill burden
(pills/day/patient)
Pill burden from PBs
(pills/day/patient)
Gender (male) β
(P)
  0.097
0.040
  
Age (years) β
(P)
- 0.110
0.011
- 0.250
< 0.001
- 0.090
0.037
- 0.255
< 0.001
Dialysis vintage (years) β
(P)
0.290
< 0.001
0.175
< 0.001
0.220
< 0.001
0.145
0.003
DM (yes) β
(P)
0.135
0.003
  0.141
0.001
 
Serum P (mg/dL) β
(P)
0.210
< 0.001
0.144
0.003
0.196
< 0.001
0.140
0.004
Oral calcimimetics (user) β
(P)
   0.175
<0.001
0.106
0.032
IV calcimimetics (user) β
(P)
   0.094
0.034
 
  1. Independent variables in model 1; gender (male), age (years), dialysis vintage (years), DM (yes), serum corrected Ca (mg/dL), serum P (mg/dL), serum i-PTH (pg/mL), serum Alb (g/dL), and nPCR (g/kg/day). Independent variables in model 2; model 1 + oral calcimimetics (user), IV calcimimetics (user), oral VDRAs (user), and IV VDRAs (user)
\